Literature DB >> 1379457

Regulation of cellular immune responses by selenium.

L Kiremidjian-Schumacher1, M Roy, H I Wishe, M W Cohen, G Stotzky.   

Abstract

Selenium (Se) is an essential nutritional factor that affects the development and expression of cell-mediated immune responses directed toward malignant cells. These studies have shown that dietary (2 ppm for 8 wk) or in in vitro (1 x 10(-7)M) supplementation with Se (as sodium selenite) results in a significant enhancement of the proliferative responses of spleen lymphocytes from C57Bl/6J mice in response to stimulation with mitogen or antigen. Se deficiency (0.02 ppm for 8 wk) had the opposite effect. The alterations in the ability of the cells to proliferate, which occurred in the absence of changes in the endogenous levels of interleukin-2 (Il2) or interleukin 1, were apparently related to the ability of Se to alter the kinetics of expression of high-affinity Il2 receptors on the surface of activated lymphocytes. This resulted in an enhanced or delayed clonal expansion of the cells, and in an increased or decreased frequency of cytotoxic cells within a given cell population. The changes in tumor cytotoxicity were paralleled by changes in the amounts of lymphotoxin produced by the activated cells. Dietary Se modulations had a comparable effect on macrophage-mediated tumor cytodestruction. The results also suggested that Se exerts its effect 8-24 h after stimulation, and that it most likely affects processes in the cytoplasmic and/or nuclear compartments of activated lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1379457     DOI: 10.1007/bf02783989

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  28 in total

1.  Selenium and immune cell functions. II. Effect on lymphocyte-mediated cytotoxicity.

Authors:  M Roy; L Kiremidjian-Schumacher; H I Wishe; M W Cohen; G Stotzky
Journal:  Proc Soc Exp Biol Med       Date:  1990-02

2.  Antioxidant effects on cell-mediated immunity.

Authors:  H C Meeker; M L Eskew; W Scheuchenzuber; R W Scholz; A Zarkower
Journal:  J Leukoc Biol       Date:  1985-10       Impact factor: 4.962

3.  Age-associated decline in precursor frequency for different T cell-mediated reactions, with preservation of helper or cytotoxic effect per precursor cell.

Authors:  R A Miller
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

4.  Association of protein kinase C activation with IL 2 receptor expression.

Authors:  W L Farrar; F W Ruscetti
Journal:  J Immunol       Date:  1986-02-15       Impact factor: 5.422

5.  Alteration of natural killer cell-mediated cytotoxicity in rats treated with selenium, diethylnitrosamine and ethylnitrosourea.

Authors:  P A Talcott; J H Exon; L D Koller
Journal:  Cancer Lett       Date:  1984-07       Impact factor: 8.679

6.  Mechanisms underlying T-lymphocyte activation: mitogen initiates and IL-2 amplifies the expression of transferrin receptors via intracellular iron level.

Authors:  E Pelosi-Testa; P Samoggia; G Giannella; E Montesoro; T Caravita; G Salvo; A Camagna; G Isacchi; U Testa; C Peschle
Journal:  Immunology       Date:  1988-06       Impact factor: 7.397

7.  Interleukin 2 receptor gene expression in normal human T lymphocytes.

Authors:  W J Leonard; M Krönke; N J Peffer; J M Depper; W C Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

8.  Retention of biological activity following radioiodination of human interleukin 2: comparison with biosynthetically labeled growth factor in receptor binding assays.

Authors:  R J Robb; P C Mayer; R Garlick
Journal:  J Immunol Methods       Date:  1985-07-16       Impact factor: 2.303

9.  Bidirectional amplification of macrophage-lymphocyte interactions: enhanced lymphocyte activation factor production by activated adherent mouse peritoneal cells.

Authors:  M S Meltzer; J J Oppenheim
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

10.  Internalization of interleukin 2 is mediated by the beta chain of the high-affinity interleukin 2 receptor.

Authors:  R J Robb; W C Greene
Journal:  J Exp Med       Date:  1987-04-01       Impact factor: 14.307

View more
  10 in total

1.  Tumor suppressor function of the plasma glutathione peroxidase gpx3 in colitis-associated carcinoma.

Authors:  Caitlyn W Barrett; Wei Ning; Xi Chen; Jesse Joshua Smith; Mary K Washington; Kristina E Hill; Lori A Coburn; Richard M Peek; Rupesh Chaturvedi; Keith T Wilson; Raymond F Burk; Christopher S Williams
Journal:  Cancer Res       Date:  2012-12-05       Impact factor: 12.701

2.  Supplementation with selenium and human immune cell functions. I. Effect on lymphocyte proliferation and interleukin 2 receptor expression.

Authors:  M Roy; L Kiremidjian-Schumacher; H I Wishe; M W Cohen; G Stotzky
Journal:  Biol Trace Elem Res       Date:  1994 Apr-May       Impact factor: 3.738

3.  Supplementation with selenium and human immune cell functions. II. Effect on cytotoxic lymphocytes and natural killer cells.

Authors:  L Kiremidjian-Schumacher; M Roy; H I Wishe; M W Cohen; G Stotzky
Journal:  Biol Trace Elem Res       Date:  1994 Apr-May       Impact factor: 3.738

4.  Selenoproteins mediate T cell immunity through an antioxidant mechanism.

Authors:  Rajeev K Shrimali; Robert D Irons; Bradley A Carlson; Yasuyo Sano; Vadim N Gladyshev; Jin Mo Park; Dolph L Hatfield
Journal:  J Biol Chem       Date:  2008-05-16       Impact factor: 5.157

Review 5.  Selenium and cellular immunity. Evidence that selenoproteins may be encoded in the +1 reading frame overlapping the human CD4, CD8, and HLA-DR genes.

Authors:  E W Taylor
Journal:  Biol Trace Elem Res       Date:  1995 Aug-Sep       Impact factor: 3.738

6.  Effect of selenium supplementation on CD4+ T-cell recovery, viral suppression and morbidity of HIV-infected patients in Rwanda: a randomized controlled trial.

Authors:  Julius Kamwesiga; Vincent Mutabazi; Josephine Kayumba; Jean-Claude K Tayari; Jean Claude Uwimbabazi; Gad Batanage; Grace Uwera; Marcel Baziruwiha; Christian Ntizimira; Antoinette Murebwayire; Jean Pierre Haguma; Julienne Nyiransabimana; Jean Bosco Nzabandora; Pascal Nzamwita; Ernestine Mukazayire
Journal:  AIDS       Date:  2015-06-01       Impact factor: 4.177

7.  Impact of Maternal Selenium Status on Infant Outcome during the First 6 Months of Life.

Authors:  Kristin Varsi; Bjørn Bolann; Ingrid Torsvik; Tina Constanse Rosvold Eik; Paul Johan Høl; Anne-Lise Bjørke-Monsen
Journal:  Nutrients       Date:  2017-05-11       Impact factor: 5.717

8.  Effects of dietary selenium on histopathological changes and T cells of spleen in broilers exposed to aflatoxin B1.

Authors:  Kejie Chen; Xi Peng; Jing Fang; Hengmin Cui; Zhicai Zuo; Junliang Deng; Zhengli Chen; Yi Geng; Weimin Lai; Li Tang; Qingqiu Yang
Journal:  Int J Environ Res Public Health       Date:  2014-02-10       Impact factor: 3.390

Review 9.  Updates on clinical studies of selenium supplementation in radiotherapy.

Authors:  Irma M Puspitasari; Rizky Abdulah; Chiho Yamazaki; Satomi Kameo; Takashi Nakano; Hiroshi Koyama
Journal:  Radiat Oncol       Date:  2014-05-29       Impact factor: 3.481

10.  Sodium selenite prevents suppression of mucosal humoral response by AFB1 in broiler's cecal tonsil.

Authors:  Chunyu Liu; Zhicai Zuo; Panpan Zhu; Zhixiang Zheng; Xi Peng; Jing Fang; Hengmin Cui; Yi Zhou; Ping Ouyang; Yi Geng; Junliang Deng; Yu Sun
Journal:  Oncotarget       Date:  2017-04-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.